Aguila Saleh to Asharq Al-Awsat: Haftar, Sarraj Meeting is Impossible

Libyan parliament Speaker Aguila Saleh. (Reuters)
Libyan parliament Speaker Aguila Saleh. (Reuters)
TT

Aguila Saleh to Asharq Al-Awsat: Haftar, Sarraj Meeting is Impossible

Libyan parliament Speaker Aguila Saleh. (Reuters)
Libyan parliament Speaker Aguila Saleh. (Reuters)

Libyan parliament Speaker Aguila Saleh blamed “some forces in the international community” for the failure of holding the elections in his country.

In an interview with Asharq Al-Awsat from Cairo, Saleh said Libyans should be encouraged to cast their ballots without foreign intervention.

“The political path from the beginning was wrong, and then the end will be certainly wrong,” he said, explaining: “The former UN envoy, Martin Kobler, was supposed to assist Libya in enforcing the laws regulating the authorities, especially as it is an independent state with laws, an elected parliament, a constitution and courts. The transition of power in these cases is known.”

“But what happened was that the Muslim Brotherhood did not get seats in parliament, so they revolted; the international community disregarded the constitution and the elected parliament, and it started dealing with a government of its choice,” Saleh noted.

“Therefore, the Libyan people cannot accept a government that was imposed by international agreement and not by their own choice. The UN mediator was supposed to be a fair mediator for all parties, not just an employee of the United Nations and international community,” he added.

Asked about the Skheirat agreement, which was signed by the Libyan parties in December 2015, Saleh noted that the Libyan people did not delegate those who participated in the agreement.

“Legitimacy is granted by the people, not by foreign forces… These mistakes led to the delay of the political solution in Libya. Today we need to remove everyone’s hands off Libya. Assistance should only be in the elections,” he emphasized.

The speaker stressed that there would be no return to the Skheirat agreement.

“But we want to go to the elections. If [Government of National Accord head Fayez] al-Sarraj has popularity, he has to resort to the ballot boxes,” he said.

On whether the current situation was adequate for holding the polls, he noted that 85 percent of the population supported this demand.

“It is the only road that will lead to a solution,” he said. “The Libyans reject all that is imposed on them from abroad. We are a united people and a cohesive social fabric, but foreign interference is distorting this cohesion.”

He said he expected the elections to be held at the beginning of 2020, adding that the Libyan National Army (LNA), African Union and international community could handle necessary security arrangements.

On Washington’s efforts to hold a meeting between LNA commander Khalifa Haftar and Presidential Council chief Sarraj, he remarked: “A meeting between them is impossible, especially after Libyans were killed and the head of the Presidential Council was blamed for it.”

Asked about his relationship with UN envoy, Ghassan Salame, Saleh emphasized that he was biased to the GNA, “which is not considered as a party to dialogue.”

“The parliament has already rejected this government and has not given it its confidence,” he added.

Furthermore, he accused Qatar and Turkey of supporting groups in Tripoli that the LNA considers "terrorist", noting that the army should “carry out its duty towards the security and stability of the homeland.”



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.